Life Sciences
The companies announced the sleep technology platform at HLTH 2022 on Sunday.
Also, Smith+Nephew has launched a digital innovation centre in Singapore.
PointClickCare's senior health-focused datasets will help to influence Pfizer's decisions on new therapies.
The partnership will offer one platform for clinical trial sponsors, sites and participants.
Also, Syntekabio has launched its cloud service platform for AI drug discovery.
Transcarent announced it would expand into the pharmacy benefit space in September.
The multinational pharma company will now be able to access Tempus' de-identified patient data.
The company also announced a partnership with pharma giant Biogen that allows providers to submit enrollment forms for its multiple sclerosis drug Vumerity through the new platform.
Dr. Oliver Bleck, area head of Europe South at Roche, describes the pharma giant's work in personalized medicine.
The collaboration aims to lower the cost of prescription drugs for Capital Blue Cross members.